New York, NY, April 9, 2025 – NMS Capital (“NMS”), a leading private equity firm focused on investments within subsectors of Healthcare Services and Business Services, today announced that it has exited its investment in U.S. Urology Partners (the “Company”) through a significant growth investment from General Atlantic, a leading global investor. NMS formed U.S. Urology Partners in 2018 with an investment in a single market group practice and through organic and inorganic growth transformed the Company into one of the nation’s largest urological care services networks encompassing over 180 providers operating throughout 50 clinical locations in five states.
U.S. Urology Partners is a leading, integrated urology platform providing a wide range of treatment options across various subspecialties including general urology, prostate and bladder oncologic conditions, clinical research, radiology, pharmacy and infusion, and robotic surgery, amongst others. The Company’s footprint consists of over 180 providers operating across a network of over 50 freestanding clinics and surgery centers throughout Florida, Indiana, Massachusetts, New York, and Ohio. U.S. Urology Partners specializes in providing end-to-end care throughout the entire patient journey and ensuring physicians have the resources necessary to practice at “top of license.” Supported by a premier executive team with extensive multi-site healthcare experience as well as a best-in-class technology suite, U.S. Urology Partners is well-positioned as the consolidator of choice within the market for urological services.
NMS’s investment in U.S. Urology Partners was the result of its thematic approach to investing in the healthcare services provider space aimed at increasing access to care and improving the patient experience in a lower cost community-based setting. As one of the first institutionally-backed platforms of scale within the urological provider space U.S. Urology Partners is committed to delivering patients superior outcomes through its integrated care model and robust ancillary offering by investing in end-to-end clinical capabilities for both urology and genitourinary oncology. During its ownership, NMS supported U.S. Urology Partners via significant infrastructure, technology, and provider recruitment investment, the hiring of a purpose-built executive team, partnerships with five market-leading provider groups and other subsequent tuck-in affiliations, and the rollout of various new and expanded ancillary service lines across the platform, including outpatient robotic surgery, interventional radiology, clinical research, and chronic care management.
Corina Tracy, Chief Executive Officer of U.S. Urology Partners, commented “Our growth since formation is evidence of the unique value we provide to our patients and physician partners. We have executed against a vision to build a differentiated platform through robust corporate support and infrastructure, superior patient care, and a thoughtful physician partnership model. Our partnership with NMS has been one marked by collaboration, growth, and support and we remain excited for the platform’s next chapter.”
Luis Gonzalez, Senior Partner and Head of Healthcare at NMS, noted “NMS has a long history of partnering with management teams to support leading community-based multi-site provider practices, enabling physicians to deliver world-class care to the patients they serve while remaining autonomous. We wish Corina, our physician partners, and the entire U.S. Urology Partners team continued success in their next phase of growth with General Atlantic.”
Houlihan Lokey served as lead financial advisor to U.S. Urology Partners and NMS. Ernst & Young Capital Advisors also served as financial advisor to the Company and NMS. McDermott Will & Emery provided legal counsel to U.S. Urology Partners and NMS.
About U.S. Urology Partners:
U.S. Urology Partners offers a comprehensive suite of practice management capabilities to its affiliated community-based urology practices, which maintain their local brand and identity that they have established, often over decades. The Company currently supports five affiliated groups comprising over 180 providers across practices located in Florida, Indiana, Massachusetts, New York, and Ohio. For more information, please visit www.us-uro.com.
About NMS Capital:
Founded in 2010, NMS Capital is an experienced private equity firm managing assets in excess of $1.4 billion. Since inception, NMS has partnered with management teams in over 150 investments and follow-on acquisitions across defined investment themes within the Business Services and Healthcare Services industries. The firm’s principal strategy is to create long-term value by providing strategic and operational resources to growth-oriented companies led by founders or experienced management teams. NMS has successfully built industry leading lower middle market companies in defensible and scalable end markets by accelerating organic and acquisition-driven growth.
For additional information on NMS, please visit the firm’s website at www.nms-capital.com. Follow NMS Capital on www.linkedin.com/company/nms-capital.
For further information:
For NMS Capital:
Colin Durney
Vice President
(212) 574-7012
cdurney@nms-capital.com